TCL Archive NCI names Porter Novelli executive as director for strategic dissemination. August 1, 2003
TCL Archive Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details January 7, 1983
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
